Moroxite T

Moroxite T is a pharma company with the mission to improve survival and the quality of life of cancer patients. The company is developing its first drug product for treatment of osteosarcoma which is a type of bone cancer. Based on a patented technology platform for drug delivery of clinically well-known chemotherapeutic substances, Moroxite T is developing product candidates with substantial clinical advantages with regards to efficacy and safety in the treatment of solid cancer tumors.